MedTrace Logo

Prediction of Recurrent Events With 18F-Fluoride

NCT02278211 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 995

Last updated 2025-03-17

Study results available
· View outcomes & findings →

Summary

This is a multi-centre observational study. It will make use of the positron emission tomography (PET) tracer 18F-sodium fluoride (18F-NaF) as a marker of coronary plaque vulnerability to detect culprit and non-culprit unstable coronary plaques in patients with recent myocardial infarctions. The investigators will then perform long-term follow-up of these patients to determine the prognostic significance of coronary 18F-NaF uptake

Conditions

Sponsors & Collaborators

  • NHS Lothian

    collaborator OTHER_GOV

  • Oxford University Hospitals NHS Trust

    collaborator OTHER

  • Manchester University NHS Foundation Trust

    collaborator OTHER_GOV

  • NHS Grampian

    collaborator OTHER_GOV

  • Wellcome Trust

    collaborator OTHER

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • David Newby, PhD · University of Edinburgh

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2022-03-31
Completion
2022-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02278211 on ClinicalTrials.gov